Rapid communication Open Access
Like 0


Ebola virus can persist in semen after recovery, potentially for months, which may impact the duration of enhanced surveillance required after interruption of transmission. We combined recent data on viral RNA persistence with weekly disease incidence to estimate the current number of semen-positive men in affected West African countries. We find the number is low, and since few reported sexual transmission events have occurred, the future risk is also likely low, although sexual health promotion remains critical.


Article metrics loading...

Loading full text...

Full text loading...



  1. Deen GF, Knust B, Broutet N, Sesay FR, Formenty P, Ross C, et al. Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Preliminary Report. N Engl J Med. 2015.  https://doi.org/10.1056/NEJMoa1511410  PMID: 26465681 
  2. Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis. 1999;179(s1) Suppl 1;S28-35.  https://doi.org/10.1086/514318  PMID: 9988162 
  3. Mate SE, Kugelman JR, Nyenswah TG, Ladner JT, Wiley MR, Cordier-Lassalle T, et al. Molecular Evidence of Sexual Transmission of Ebola Virus. N Engl J Med. 2015.  https://doi.org/10.1056/NEJMoa1509773  PMID: 26465384 
  4. World Health Organization (WHO). Criteria for declaring the end of the Ebola outbreak in Guinea, Liberia or Sierra Leone. Geneva: WHO. Available from: http://www.who.int/csr/disease/ebola/declaration-ebola-end/en/
  5. World Health Organization (WHO). WHO Situation Reports Download Page. Geneva: WHO. Available from: http://apps.who.int/gho/data/node.ebola-sitrep.quick-downloads
  6. WHO Ebola Response Team. Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371(16):1481-95.  https://doi.org/10.1056/NEJMoa1411100  PMID: 25244186 
  7. Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386(9996):857-66.  https://doi.org/10.1016/S0140-6736(15)61117-5  PMID: 26248676 

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error